Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Argos Therapeutics (ARGS)

Argos Therapeutics (ARGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Argos Therapeutics 4233 TECHNOLOGY DR DURHAM NC 27704 USA

www.argostherapeutics.com P: 919-287-6300

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Argos Therapeutics is a biopharmaceutical company which focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis (TM) technology platform. Argos Therapeutics is based in Durham, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,059
Shares Outstanding, K 10,590
% of Insider Shareholders 28.21%
% of Institutional Shareholders 7.81%

Financials:

Annual Sales, $ 1,900 K
Annual Net Income, $ -40,580 K
Last Quarter Sales, $ 1,250 K
Last Quarter Net Income, $ -5,000 K

Growth:

1-Year Return -97.06%
3-Year Return -99.79%
5-Year Return 0.00%
5-Year Revenue Growth -73.01%
5-Year Earnings Growth 98.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 12/06/18
Earnings Per Share ttm -1.94
EPS Growth vs. Prev Qtr -117.86%
EPS Growth vs. Prev Year 85.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/19/18

ARGS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -106.82%
Profit Margin % -2,135.79%
Debt/Equity -1.31
Price/Sales 0.56
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.19
Interest Coverage -29.98
60-Month Beta 0.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar